Close Menu

NEW YORK – The UK Health and Social Care Secretary announced late on Wednesday a £500 million ($667 million) investment in new SARS-CoV-2 testing technology to increase the country's testing capacity.

The new funding builds on an initiative announced in August by the UK's Department of Health and Social Care (DHSC) to roll out rapid coronavirus tests from DnaNudge and Oxford Nanopore Technologies to hospitals, care homes, and laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.